Reynolds Investment Management, Inc. Abbott Laboratories Transaction History
Reynolds Investment Management, Inc.
- $281 Million
- Q2 2022
A detailed history of Reynolds Investment Management, Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, Reynolds Investment Management, Inc. holds 3,726 shares of ABT stock, worth $436,426. This represents 0.14% of its overall portfolio holdings.
Number of Shares
3,726
Previous 3,862
3.52%
Holding current value
$436,426
Previous $457,000
11.38%
% of portfolio
0.14%
Previous 0.13%
Shares
2 transactions
Others Institutions Holding ABT
# of Institutions
3,185Shares Held
1.3BCall Options Held
8.74MPut Options Held
8.08M-
Vanguard Group Inc Valley Forge, PA168MShares$19.7 Billion0.35% of portfolio
-
Black Rock Inc. New York, NY131MShares$15.4 Billion0.31% of portfolio
-
State Street Corp Boston, MA76.7MShares$8.99 Billion0.36% of portfolio
-
Capital International Investors Los Angeles, CA65.7MShares$7.7 Billion1.49% of portfolio
-
Capital Research Global Investors Los Angeles, CA53.3MShares$6.24 Billion1.31% of portfolio
About ABBOTT LABORATORIES
- Ticker ABT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,751,219,968
- Market Cap $205B
- Description
- Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...